Welcome to our online store!

More Views

Ibrans 21 capsules 125mg palbociclib Ибранс

Product sku: MD3332

Availability: In stock

Only 15 left


Quick Overview

Cancer treatment


Ibransa Indications

Treatment of hormone receptor-positive (HR-positive), negative human epidermal growth factor receptor 2 (HER2) locally advanced or metastatic breast cancer:

- combination with an aromatase inhibitor;
- combination with fulvestrant in women who had previously received endocrine therapy.
Women with premenopausal and perimenopause, endocrine therapy should be performed in combination with a luteinizing hormone releasing hormone agonist


Hypersensitivity to the active substance or to any of the excipients of the drug. The use of drugs containing St. John's wort

Dosage & Administration

Treatment with Ibrens should be initiated and supervised by a physician experienced in the use of anticancer drugs.

The recommended dose is 125 mg of palbocyclone orally once a day for 21 consecutive days followed by a 7-day break (mode 3/1) to form a full cycle of 28 days.

Treatment should be continued as long as the clinical efficacy of the therapy is maintained or until its unacceptable toxic effects persist.

Additional Information

Color No

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.